[HTML][HTML] Is the cholesteryl ester transfer protein proatherogenic or antiatherogenic in humans?
M Cuchel, DJ Rader - Journal of the American College of Cardiology, 2007 - jacc.org
M Cuchel, DJ Rader
Journal of the American College of Cardiology, 2007•jacc.orgThe strong inverse association of plasma levels of highdensity lipoprotein cholesterol (HDL-
C) with coronary heart disease (CHD) has long tantalized the preventive cardiovascular
medicine community with the prospect of new therapies that raise levels of HDL-C and thus
reduce the risk of CHD. The finding that markedly elevated HDL-C levels are caused by
genetic deficiency of the cholesteryl ester transfer protein (CETP) and, subsequently,
C) with coronary heart disease (CHD) has long tantalized the preventive cardiovascular
medicine community with the prospect of new therapies that raise levels of HDL-C and thus
reduce the risk of CHD. The finding that markedly elevated HDL-C levels are caused by
genetic deficiency of the cholesteryl ester transfer protein (CETP) and, subsequently,
The strong inverse association of plasma levels of highdensity lipoprotein cholesterol (HDL-C) with coronary heart disease (CHD) has long tantalized the preventive cardiovascular medicine community with the prospect of new therapies that raise levels of HDL-C and thus reduce the risk of CHD. The finding that markedly elevated HDL-C levels are caused by genetic deficiency of the cholesteryl ester transfer protein (CETP) and, subsequently,
jacc.org